The global Pain Management Drugs market size was valued at US$ 38850 million in 2024 and is forecast to a readjusted size of USD 48390 million by 2031 with a CAGR of 3.2% during review period.
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.
This report is a detailed and comprehensive analysis for global Pain Management Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pain Management Drugs market size and forecasts, in consumption value ($ Million), 2020-2031
Global Pain Management Drugs market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Pain Management Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Pain Management Drugs market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pain Management Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pain Management Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo, Merck, Yunnan Baiyao, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Pain Management Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Generic Opioids
Branded Opioids
NSAIDs
Others
麻豆原创 segment by Application
Hospitals
Drugstores
Others
麻豆原创 segment by players, this report covers
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pain Management Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pain Management Drugs, with revenue, gross margin, and global market share of Pain Management Drugs from 2020 to 2025.
Chapter 3, the Pain Management Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Pain Management Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pain Management Drugs.
Chapter 13, to describe Pain Management Drugs research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Pain Management Drugs by Type
1.3.1 Overview: Global Pain Management Drugs 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Pain Management Drugs Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Generic Opioids
1.3.4 Branded Opioids
1.3.5 NSAIDs
1.3.6 Others
1.4 Global Pain Management Drugs 麻豆原创 by Application
1.4.1 Overview: Global Pain Management Drugs 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Drugstores
1.4.4 Others
1.5 Global Pain Management Drugs 麻豆原创 Size & Forecast
1.6 Global Pain Management Drugs 麻豆原创 Size and Forecast by Region
1.6.1 Global Pain Management Drugs 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Pain Management Drugs 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Pain Management Drugs 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Pain Management Drugs 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Pain Management Drugs 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Pain Management Drugs 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Pain Management Drugs 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Pain Management Drugs Product and Solutions
2.1.4 GSK Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 GSK Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Pain Management Drugs Product and Solutions
2.2.4 Pfizer Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Grunenthal
2.3.1 Grunenthal Details
2.3.2 Grunenthal Major Business
2.3.3 Grunenthal Pain Management Drugs Product and Solutions
2.3.4 Grunenthal Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Grunenthal Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Pain Management Drugs Product and Solutions
2.4.4 Sanofi Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Pain Management Drugs Product and Solutions
2.5.4 Bayer Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Bayer Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Pain Management Drugs Product and Solutions
2.6.4 AstraZeneca Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Pain Management Drugs Product and Solutions
2.7.4 Eli Lilly Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Eli Lilly Recent Developments and Future Plans
2.8 Endo
2.8.1 Endo Details
2.8.2 Endo Major Business
2.8.3 Endo Pain Management Drugs Product and Solutions
2.8.4 Endo Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Endo Recent Developments and Future Plans
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Pain Management Drugs Product and Solutions
2.9.4 Merck Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Merck Recent Developments and Future Plans
2.10 Yunnan Baiyao
2.10.1 Yunnan Baiyao Details
2.10.2 Yunnan Baiyao Major Business
2.10.3 Yunnan Baiyao Pain Management Drugs Product and Solutions
2.10.4 Yunnan Baiyao Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Yunnan Baiyao Recent Developments and Future Plans
2.11 Teikoku Seiyaku
2.11.1 Teikoku Seiyaku Details
2.11.2 Teikoku Seiyaku Major Business
2.11.3 Teikoku Seiyaku Pain Management Drugs Product and Solutions
2.11.4 Teikoku Seiyaku Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Teikoku Seiyaku Recent Developments and Future Plans
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Pain Management Drugs Product and Solutions
2.12.4 Teva Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Teva Recent Developments and Future Plans
2.13 J&J
2.13.1 J&J Details
2.13.2 J&J Major Business
2.13.3 J&J Pain Management Drugs Product and Solutions
2.13.4 J&J Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 J&J Recent Developments and Future Plans
2.14 Assertio Therapeutics
2.14.1 Assertio Therapeutics Details
2.14.2 Assertio Therapeutics Major Business
2.14.3 Assertio Therapeutics Pain Management Drugs Product and Solutions
2.14.4 Assertio Therapeutics Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Assertio Therapeutics Recent Developments and Future Plans
2.15 Allergan
2.15.1 Allergan Details
2.15.2 Allergan Major Business
2.15.3 Allergan Pain Management Drugs Product and Solutions
2.15.4 Allergan Pain Management Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Allergan Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Pain Management Drugs Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Pain Management Drugs by Company Revenue
3.2.2 Top 3 Pain Management Drugs Players 麻豆原创 Share in 2024
3.2.3 Top 6 Pain Management Drugs Players 麻豆原创 Share in 2024
3.3 Pain Management Drugs 麻豆原创: Overall Company Footprint Analysis
3.3.1 Pain Management Drugs 麻豆原创: Region Footprint
3.3.2 Pain Management Drugs 麻豆原创: Company Product Type Footprint
3.3.3 Pain Management Drugs 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Pain Management Drugs Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Pain Management Drugs 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Pain Management Drugs Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Pain Management Drugs 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Pain Management Drugs Consumption Value by Type (2020-2031)
6.2 North America Pain Management Drugs 麻豆原创 Size by Application (2020-2031)
6.3 North America Pain Management Drugs 麻豆原创 Size by Country
6.3.1 North America Pain Management Drugs Consumption Value by Country (2020-2031)
6.3.2 United States Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Pain Management Drugs Consumption Value by Type (2020-2031)
7.2 Europe Pain Management Drugs Consumption Value by Application (2020-2031)
7.3 Europe Pain Management Drugs 麻豆原创 Size by Country
7.3.1 Europe Pain Management Drugs Consumption Value by Country (2020-2031)
7.3.2 Germany Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Pain Management Drugs Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Pain Management Drugs Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Pain Management Drugs 麻豆原创 Size by Region
8.3.1 Asia-Pacific Pain Management Drugs Consumption Value by Region (2020-2031)
8.3.2 China Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Pain Management Drugs Consumption Value by Type (2020-2031)
9.2 South America Pain Management Drugs Consumption Value by Application (2020-2031)
9.3 South America Pain Management Drugs 麻豆原创 Size by Country
9.3.1 South America Pain Management Drugs Consumption Value by Country (2020-2031)
9.3.2 Brazil Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Pain Management Drugs Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Pain Management Drugs Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Pain Management Drugs 麻豆原创 Size by Country
10.3.1 Middle East & Africa Pain Management Drugs Consumption Value by Country (2020-2031)
10.3.2 Turkey Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Pain Management Drugs 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Pain Management Drugs 麻豆原创 Drivers
11.2 Pain Management Drugs 麻豆原创 Restraints
11.3 Pain Management Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Pain Management Drugs Industry Chain
12.2 Pain Management Drugs Upstream Analysis
12.3 Pain Management Drugs Midstream Analysis
12.4 Pain Management Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
听
听
*If Applicable.
